HSJ Partnership Awards will showcase pharma’s inspirational joint working projects with the NHS
August 23, 2018 |
Health Service Journal (HSJ), the news and information service for all healthcare leaders working in, for, or with the NHS, has expanded and enhanced its Partnership Awards for 2019.
NEWS RELEASE 23 August 2018
2019 HSJ Partnership Awards will showcase pharma’s inspirational joint working projects with the NHS
Health Service Journal (HSJ), the news and information service for all healthcare leaders working in, for, or with the NHS, has expanded and enhanced its Partnership Awards for 2019. This follows the success of its inaugural programme earlier this year where Merck, Sharp and Dohme were recognised for Best Pharmaceutical Partnership with the NHS for their role in the NHS England Test Bed programme.
The newly launched 2019 Partnership Awards, which recognise private sector organisations, including pharma companies, that are working to help the NHS deliver better and more cost-effective patient care, boast several new categories and a prestigious black tie dinner awards ceremony at Park Plaza, Westminster Bridge on 20 March 2019 Featuring a total of 21 different categories, covering a broad swathe of sectors, the expanded programme now has new categories, including mental health consultancies and not-for-profit organisations.
A vast range of joint working projects and service providers will be eligible for recognition. Entrants must be able to demonstrate that their projects have made a tangible difference to the NHS by, for example, improving services, facilities or quality of life for patients, or working more efficiently to save money. Winning entries in the 2018 HSJ Partnership Awards included new payroll systems, a new clinical pathway for leg ulcers and an alternative dispute resolution protocol tool, with each project demonstrating clear benefits to NHS organisations.
Alastair McLellan, Editor of HSJ, said: “Hundreds of organisations, across numerous sectors, work behind the scenes to assist the NHS. However, their contributions are often unseen and not given due credit. The HSJ Partnership Awards provide the opportunity to celebrate the work of these invaluable contributors who are delivering tangible benefits to NHS patients, clinicians and the facilities they use.
“Building on the tremendous success of the first HSJ Partnership Awards, we have adopted a black tie dinner format, similar to that used for our HSJ Awards programme. The glamorous evening will showcase the innovative projects and long-term support programmes that are really making a difference to the NHS in these challenging economic times.”
For details on the individual categories and entry criteria, please log on to www.partnership.hsj.co.uk.
Entries must be submitted by 26 October 2018.
ENDS
FOR MORE INFORMATION AND IMAGE REQUESTS: Andrew Baud, Tala, 020 3397 3383 or 07775 715775, andrew.baud@teamtala.com
This content was provided by Wilmington Healthcare
Company Details
Latest Content from Wilmington Healthcare
Wilmington Healthcare launches new platform to map the formulary landscape
Healthcare intelligence provider Wilmington Healthcare has launched a new platform that enables pharma companies to develop a clear picture of formulary status across therapy areas and territories in the UK.
Wilmington Healthcare appoints new Head of Digital
Wilmington Healthcare, which provides data, insight and intelligence for pharma and medtech companies, has appointed Pfizer’s former UK Digital Marketing Manager, Mikko Figura, as Head of Digital.In his new role,...
How has the pandemic reshaped the NHS in 2020?
Oli Hudson, of Wilmington Healthcare, explores the major changes that have occurred across the NHS as key aspects of the Long Term Plan are rolled out at speed.
Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset
How can pharma align its brand strategy with the NHS Reset?
Oli Hudson, of Wilmington Healthcare, explores how pharma should respond to plans to ‘reboot’ the NHS during the covid recovery era
Covid-19 redefines rules of customer engagement
Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs
White paper helps industry navigate new NHS roadmap
New report shows how pharma can support the NHS in the Covid-19 recovery era
Covid-19 drives change in long-term conditions management
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are being empowered to manage their conditions at home
Covid-19: how is it impacting on the NHS Long-term Plan?
Oli Hudson and Paul Midgley, of Wilmington Healthcare, explain how coronavirus has expedited some parts of the plan but put others in jeopardy
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it